INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 01/22/2025 at 22:05, 1 year ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year ago

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D

Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
BRIEF

published on 12/17/2024 at 22:05, 1 year 1 month ago

Inventiva to present at the JP Morgan Healthcare Conference

Investors Inventiva NASH Lanifibranor JP Morgan Healthcare
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 1 month ago

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings

Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction
BRIEF

published on 12/12/2024 at 22:05, 1 year 1 month ago

Inventiva Announces Shareholders’ Meeting Vote Results

Voting Results Shareholders' Meeting Biopharmaceutical Resolutions Inventiva
PRESS RELEASE

published on 12/12/2024 at 22:00, 1 year 1 month ago

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024
Inventiva announces voting results of Combined Shareholders' General Meeting on December 11, 2024. All resolutions were adopted except the 59th resolution

Voting Results Shareholders' Meeting Clinical-Stage Biopharmaceutical Inventiva NASH
BRIEF

published on 11/21/2024 at 22:05, 1 year 2 months ago

Inventiva's Financial Overview for Q3 2024

Financial Results Cash Position Equity Raise Royalty Certificates R&D Expenses
PRESS RELEASE

published on 11/21/2024 at 22:00, 1 year 2 months ago

Inventiva reports 2024 Third Quarter Financial Information¹
Inventiva reports strong financial position with €13.9 million cash at September 30, 2024. R&D expenses down 10% in 2024. Key milestones and future conference participation announced

Financial Information Cash Position Inventiva R&D Expenses Key Milestones
BRIEF

published on 11/20/2024 at 22:05, 1 year 2 months ago

Inventiva Combined General Meeting: Documents Available

Funding Documents General Assembly Inventiva NASH
PRESS RELEASE

published on 11/20/2024 at 22:00, 1 year 2 months ago

Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
Inventiva reports total voting rights and shares as of November 4, 2024, in accordance with Article R. 22-10-23 of the French Commercial Code. The company is a clinical-stage biopharmaceutical with a focus on oral small molecule therapies

Shares Total Voting Rights Clinical-Stage Biopharmaceutical Inventiva MASH/NASH

Accesswire

Published on 02/07/2026 at 01:00, 1 day 12 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 14 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 15 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 21 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 23 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 16 hours 15 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 20 hours 40 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 20 hours 55 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 17 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 19 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 18 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 21 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 17 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 18 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 19 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE